About PathoQuest
PathoQuest is a company based in Paris (France) founded in 2010 was acquired by Charles River Laboratories in January 2026. PathoQuest has raised $9.99 million across 4 funding rounds from investors including Charles River Laboratories, Eurazeo and Idinvest Partners. PathoQuest offers products and services including iDTECT Platform, Adventitious Virus Testing, Cell Line Characterization, and Raw Material Testing. PathoQuest operates in a competitive market with competitors including Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.99 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Charles River Laboratories
& 9 more
-
Employee Count
Not available
-
Acquired by
Charles River Laboratories
(Jan 13, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PathoQuest
PathoQuest offers a comprehensive portfolio of products and services, including iDTECT Platform, Adventitious Virus Testing, Cell Line Characterization, and Raw Material Testing.
Platform for viral safety and genetic characterization of biopharmaceuticals
Detects viral contamination in manufacturing processes
Screens and tests manufacturing cells for stability
Screens high-risk inputs for potential contaminants
People of PathoQuest
Unlock access to complete
Unlock access to complete
Funding Insights of PathoQuest
PathoQuest has successfully raised a total of $9.99M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PathoQuest
PathoQuest has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Charles River Laboratories, Eurazeo and Idinvest Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare-focused private equity investments are managed by SHS Capital.
|
Locked | Locked | Locked | |
|
Private equity investments are made in companies across diverse sectors.
|
Locked | Locked | Locked | |
|
Biotech startups are funded through venture capital in life sciences.
|
Locked | Locked | Locked |
Investor details for PathoQuest
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PathoQuest
Investment portfolio details for PathoQuest
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PathoQuest
Detailed financials for PathoQuest
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pathoquest Comparisons
Peer comparison for PathoQuest
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PathoQuest
PathoQuest operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Karius, Day Zero Diagnostics, OpGen and Clear Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
|
| Locked | Locked | Locked |
Viral infection treatments are developed using nucleic acid hybrid chemistry.
|
Detailed competitors of PathoQuest
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pathoquest
Complete news archive for PathoQuest
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PathoQuest
PathoQuest was founded in 2010 and raised its 1st funding round 3 years after it was founded.
PathoQuest is headquartered in Paris, France.
PathoQuest is a funded company, having raised a total of $9.99M across 4 funding rounds to date.
PathoQuest was founded in 2010 and is based in Paris, France. Operations focus on the biotechnology sector, where next-generation sequencing is integrated with sample preparation, cloud-based bioinformatics, and a pathogen genome database for automated analysis. Services support quality control in biologicals and infection diagnosis through these combined technologies.
PathoQuest's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
PathoQuest offers iDTECT Platform, Adventitious Virus Testing, Cell Line Characterization, and Raw Material Testing.
PathoQuest has 10 investors. Key investors include Charles River Laboratories, Eurazeo, Idinvest Partners, Kurma Partners, and SHS Capital.